news & events
portfolio news
08.08.12
TiGenix completes patient enrollment in Phase IIa rheumatoid arthritis study
17.07.12
TiGenix signs up 4th major hospital in the Netherlands for innovative cartilage repair therapy
10.07.12
TiGenix enrolls first patients in pivotal Phase III trial with lead product Cx601 in perianal fistulas
02.07.12
TiGenix reports positive results of Cx621 Phase I
28.06.12
Ysios Capital leads a € 2M Series A round of Inbiomotion
13.06.12
Endosense completes enrollment in toccastar ide study of its Tacticath force-sensing ablation catheter
12.06.12
Endosense announces ce mark approval, first clinical use of the New tacticath® quartz force-sensing ablation catheter
08.06.12
TiGenix obtains national reimbursement in the Netherlands for breakthrough cartilage therapy ChondroCelect®
15.05.12
TiGenix Reports Business & Financial Results for the First Quarter 2012
14.05.12
Endosense reports strong momentum for contact-force sensing in catheter ablation at heart rhythm 2012.
